Cardiology and Therapy View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2012

PUBLISHER

Springer Healthcare

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/40119

Recent publications latest 20 shown

  • 2019-04-10 Development and Psychometric Evaluation of Coronary Artery Disease Treatment Adherence Scale.
  • 2019-03-09 Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies
  • 2019-03-07 Left Ventricular Diastolic Dysfunction and Transcatheter Aortic Valve Replacement Outcomes: A Review
  • 2019-03-01 Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method
  • 2019-02-20 Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study
  • 2019-02-18 Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial
  • 2019-02-16 Dynamic Piston Function of the Mitral Annulus to Assess Early Left Ventricular Diastolic Filling: A Proof of Concept Study
  • 2019-02-13 Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
  • 2019-02-11 Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study
  • 2019-01-30 Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention
  • 2019-01-25 Cardiology and Therapy: A Summary of 2018 and Key Areas of Emerging Research in 2019
  • 2019-01-09 Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease
  • 2018-12-12 Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence
  • 2018-12 Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
  • 2018-12 Adherent Intrapericardial Teratoma: A Case Report
  • 2018-12 Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience
  • 2018-12 Effect of Erythropoietin Administration on Myocardial Viability and Coronary Microvascular Dysfunction in Anterior Acute Myocardial Infarction: Randomized Controlled Trial in the Japanese Population
  • 2018-12 Effects of Neostigmine and Sugammadex for Reversal of Neuromuscular Blockade on QT Dispersion Under Propofol Anesthesia: A Randomized Controlled Trial
  • 2018-12 A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent
  • 2018-12 Correction to: A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33002", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Internal Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33037", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Cardiology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.398", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.843", 
            "type": "Rating"
          }
        ], 
        "description": "

    Aims and Scope
    Cardiology and Therapy is an international, open access, peer reviewed (single-blind), rapid-publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of cardiovascular therapies and interventions, including devices. Studies relating to diagnosis and diagnostics, pharmacoeconomics, public health, quality of life, as well as patient care, management and education are also encouraged.\u00a0

    Areas of focus include, but are not limited to, ischaemic heart disease and acute cardiac care, myocardial, valvular, pericardial and congenital heart disease, vascular and pulmonary disease (including hypertension), arrhythmias, heart failure, non-invasive diagnostic techniques, and invasive and interventional cardiology as well as cardiovascular surgery.\u00a0

    The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols and short communications such as commentaries and editorials. Cardiolology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.

    Rapid Publication
    The journal\u2019s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3\u20134 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal\u2019s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of ophthalmic therapies.

    Personal Service
    The journal\u2019s dedicated in-house editorial team offer a personal \u201cconcierge service\u201d meaning authors will always have an editorial contact able to update them on the status of their manuscript.\u00a0 The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.

    Enhanced Digital Features
    Cardiology and Therapy offers a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include other enhanced digital features including (but not limited to) slide sets, videos, video abstracts, podcasts, infographics and animations. All these enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. By having a choice of media not limited to text, figures and tables alone, readers may receive information more effectively, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research. For questions relating specifically to these features, please contact adisdigitalfeatures@springer.com.

    Plain Language Summaries

    Articles published in Cardiology and Therapy may be accompanied by plain language summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. Both the enhanced digital features and plain language summaries can help to reach a broader audience thus supporting the effective dissemination of research.

    Publication Fees
    Upon acceptance of your article for publication, authors will be required to pay the article processing charge and open access fee of \u20ac340/$380 per typeset page. The journal will consider fee discounts for developing countries and this is decided on a case by case basis. Considering the time and effort required for a detailed peer review we also reward our regular reviewers with the opportunity to publish without article processing charges (pending peer review) for every three reviews completed per calendar year.\u00a0

    Peer Review Process
    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.

    Copyright
    Cardiology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    Contact
    For more information about the journal, including pre-submission enquiries, please contact laura.hughes@springer.com

    ", "editor": [ { "familyName": "Menown", "givenName": "Ian", "type": "Person" } ], "id": "sg:journal.1050274", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2193-8261", "2193-6544" ], "license": "Fully Open Access", "name": "Cardiology and Therapy", "productId": [ { "name": "scopus_id", "type": "PropertyValue", "value": [ "21100469942" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "2193-8261/CARDIOLOGY AND THERAPY" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101634495" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40119" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2014243464" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "50274" ] } ], "publisher": { "name": "Springer Healthcare", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1050274" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "2012", "type": "Periodical", "url": "http://link.springer.com/journal/40119" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1050274'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1050274'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1050274'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1050274'


     

    This table displays all metadata directly associated to this object as RDF triples.

    72 TRIPLES      21 PREDICATES      30 URIs      24 LITERALS      11 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1050274 schema:about sg:ontologies/product-market-codes/H33002
    2 sg:ontologies/product-market-codes/H33037
    3 schema:contentRating N09fb26f8b4bc4cca98c4320cd07e194e
    4 N8858883c71b04edd93bb027f18fa337c
    5 schema:description <p><b>Aims and Scope</b><br/><i>Cardiology and Therapy</i> is an international, open access, peer reviewed (single-blind), rapid-publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of cardiovascular therapies and interventions, including devices. Studies relating to diagnosis and diagnostics, pharmacoeconomics, public health, quality of life, as well as patient care, management and education are also encouraged.  <br/><br/>Areas of focus include, but are not limited to, ischaemic heart disease and acute cardiac care, myocardial, valvular, pericardial and congenital heart disease, vascular and pulmonary disease (including hypertension), arrhythmias, heart failure, non-invasive diagnostic techniques, and invasive and interventional cardiology as well as cardiovascular surgery.  <br/><br/>The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols and short communications such as commentaries and editorials. <i>Cardiolology and Therapy</i> will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.<br/><br/><b>Rapid Publication</b><br/>The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of ophthalmic therapies.</p><p><b>Personal Service</b><br/>The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript.  The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.</p><p><b>Enhanced Digital Features</b><br/><i>Cardiology and Therapy</i> offers a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include other enhanced digital features including (but not limited to) slide sets, videos, video abstracts, podcasts, infographics and animations. All these enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. By having a choice of media not limited to text, figures and tables alone, readers may receive information more effectively, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research. For questions relating specifically to these features, please contact adisdigitalfeatures@springer.com.<b><br/></b><b><br/>Plain Language Summaries</b><br/>Articles published in <i>Cardiology and Therapy</i> may be accompanied by plain language summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. Both the enhanced digital features and plain language summaries can help to reach a broader audience thus supporting the effective dissemination of research.<br/><br/><b>Publication Fees</b><br/>Upon acceptance of your article for publication, authors will be required to pay the article processing charge and open access fee of €340/$380 per typeset page. The journal will consider fee discounts for developing countries and this is decided on a case by case basis. Considering the time and effort required for a detailed peer review we also reward our regular reviewers with the opportunity to publish without article processing charges (pending peer review) for every three reviews completed per calendar year.  <br/><br/><b>Peer Review Process</b><br/>Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.<br/><br/>At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.<br/><br/><b>Copyright</b><br/><i>Cardiology and Therapy</i> is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.<br/><br/><b>Contact</b><br/>For more information about the journal, including pre-submission enquiries, please contact laura.hughes@springer.com </p>
    6 schema:editor N2e0496c88aa94451aa578139b4aed7b7
    7 schema:inLanguage en
    8 schema:isAccessibleForFree true
    9 schema:issn 2193-6544
    10 2193-8261
    11 schema:license Fully Open Access
    12 schema:name Cardiology and Therapy
    13 schema:productId N08833c245ed14d6c96fb1b063360429e
    14 N28c480cd63414fb8a17aa720dd8ad389
    15 N8903071a3a3f42d180914f0c678b48ae
    16 Nacb6e6a594a94d80bae229d290ecbba2
    17 Nc7ae6e8df8d440838dd13234c7714875
    18 Nca48f066646d4045ab537a1bbdb138f0
    19 schema:publisher N3ab2bd4a23724103b9e3efa708d28b2e
    20 schema:publisherImprint Adis
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1050274
    22 schema:sdDatePublished 2019-03-18T11:05
    23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    24 schema:sdPublisher Nef50674f2f784a8a9643bf6006938f0c
    25 schema:startYear 2012
    26 schema:url http://link.springer.com/journal/40119
    27 sgo:license sg:explorer/license/
    28 sgo:sdDataset journals
    29 rdf:type schema:Periodical
    30 N08833c245ed14d6c96fb1b063360429e schema:name nlm_unique_id
    31 schema:value 101634495
    32 rdf:type schema:PropertyValue
    33 N09fb26f8b4bc4cca98c4320cd07e194e schema:author N46cdbb982d2e423b97ce6fb264067801
    34 schema:ratingValue 0.398
    35 rdf:type schema:Rating
    36 N28c480cd63414fb8a17aa720dd8ad389 schema:name wos_id
    37 schema:value 2193-8261/CARDIOLOGY AND THERAPY
    38 rdf:type schema:PropertyValue
    39 N2e0496c88aa94451aa578139b4aed7b7 rdf:first Nc0c91f89435b41d4a1ca495854365a6a
    40 rdf:rest rdf:nil
    41 N3ab2bd4a23724103b9e3efa708d28b2e schema:name Springer Healthcare
    42 rdf:type schema:Organization
    43 N46cdbb982d2e423b97ce6fb264067801 rdf:first snip
    44 rdf:rest rdf:nil
    45 N8858883c71b04edd93bb027f18fa337c schema:author N9a568e8f8b4841fc86214ab9ae24a2b8
    46 schema:ratingValue 0.843
    47 rdf:type schema:Rating
    48 N8903071a3a3f42d180914f0c678b48ae schema:name dimensions_id
    49 schema:value 50274
    50 rdf:type schema:PropertyValue
    51 N9a568e8f8b4841fc86214ab9ae24a2b8 rdf:first sjr
    52 rdf:rest rdf:nil
    53 Nacb6e6a594a94d80bae229d290ecbba2 schema:name lccn_id
    54 schema:value 2014243464
    55 rdf:type schema:PropertyValue
    56 Nc0c91f89435b41d4a1ca495854365a6a schema:familyName Menown
    57 schema:givenName Ian
    58 rdf:type schema:Person
    59 Nc7ae6e8df8d440838dd13234c7714875 schema:name springer_id
    60 schema:value 40119
    61 rdf:type schema:PropertyValue
    62 Nca48f066646d4045ab537a1bbdb138f0 schema:name scopus_id
    63 schema:value 21100469942
    64 rdf:type schema:PropertyValue
    65 Nef50674f2f784a8a9643bf6006938f0c schema:name Springer Nature - SN SciGraph project
    66 rdf:type schema:Organization
    67 sg:ontologies/product-market-codes/H33002 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    68 schema:name Internal Medicine
    69 rdf:type schema:DefinedTerm
    70 sg:ontologies/product-market-codes/H33037 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    71 schema:name Cardiology
    72 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...